Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Capital Expenditures (2016 - 2025)

Vycor Medical has reported Capital Expenditures over the past 16 years, most recently at $1605.0 for Q4 2025.

  • Quarterly Capital Expenditures rose 80350.0% to $1605.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7508.0 through Dec 2025, up 36.91% year-over-year, with the annual reading at $5224.0 for FY2025, 2.65% down from the prior year.
  • Capital Expenditures was $1605.0 for Q4 2025 at Vycor Medical, up from $1.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $23935.0 in Q1 2021 and troughed at -$322.0 in Q4 2022.
  • The 5-year median for Capital Expenditures is $803.0 (2025), against an average of $4546.5.
  • Year-over-year, Capital Expenditures crashed 116.41% in 2021 and then surged 80350.0% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at -$315.0 in 2021, then dropped by 2.22% to -$322.0 in 2022, then soared by 1933.54% to $5904.0 in 2023, then tumbled by 100.03% to -$2.0 in 2024, then surged by 80350.0% to $1605.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Capital Expenditures are $1605.0 (Q4 2025), $1.0 (Q3 2025), and -$2.0 (Q4 2024).